NAS Universal Training Solution – Faculty


PatrickS Stephen W. Patrick MD, MPH, MS* is an Assistant Professor of Pediatrics in the Division of Neonatology and a Scholar within the Center for Health Services Research at Vanderbilt University. Dr. Patrick is focused on improving public health systems to optimize maternal and child health. He is a health services researcher with focus in Medicaid policy, eliminating healthcare-associated infections and improving the quality of care delivered to substance-exposed newborns including those having drug withdrawal (neonatal abstinence syndrome). read more

His neonatal abstinence syndrome research focuses on 1) understanding national trends in healthcare utilization patterns, 2) understanding variation in hospital care, 3) understanding readmission risk following initial birth hospitalization and 4) understanding the impact of different antenatal exposures on development of the syndrome. He serves as Senior Science Policy Advisor to the White House Office of National Drug Control Policy. He is a member of the scientific advisory committee and is co-author of the improvement toolkit for an international effort to improve care delivered to infants with neonatal abstinence syndrome and their families through the Vermont Oxford Network. Dr. Patrick’s awards include the American Medical Association Foundation Excellence in Medicine Leadership Award and the Academic Pediatric Association Fellow Research Award. He is a graduate of the University of Florida, Florida State University College of Medicine, Harvard School of Public Health, University of Michigan and is a former Robert Wood Johnson Foundation Clinical Scholar.

SchumacherR Robert Schumacher MD* is a Professor of Pediatrics and neonatologist at the University of Michigan in Ann Arbor, Michigan. He is the Medical Director of the Brandon NICU at the University of Michigan. He holds a certificate in medical education from the University of Michigan and a certificate in How to teach Evidence Based Medicine from McMaster University. read more

He participated in the University of Michigan’s Lean Healthcare initiative, receiving training in how to apply lean concepts, tools and techniques in the healthcare enterprise. As a clinical investigator Dr. Schumacher has participated in multiple studies ranging from the use of ECMO in full term infants to artificial surfactant therapy in VVLBW infants. He leads multiple quality improvement projects including standardizing the treatment of narcotic-exposed infants, and has presented results at an international conference. He and his coauthor, Dr Stephen Patrick collaborated on a recent paper “Neonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009” JAMA online first April 30 2012. His interests include the role of anecdotes in medicine, evidence-based medicine, and medical decision-making.

HudakM Mark Hudak MD is a tenured Professor of Pediatrics and is Board Certified in Perinatal-Neonatal Medicine. He earned his medical degree at The Johns Hopkins University School of Medicine in Baltimore, where he also completed his Pediatrics residency and neonatology fellowship. Dr. Hudak served on the Faculty at Johns Hopkins and was an Associate Professor at the State University of New York at Buffalo and Medical Director of the Neonatal Intensive Care Unit at Children’s Hospital of Buffalo. read more

He joined the UF College of Medicine – Jacksonville in 1995 as a Professor of Pediatrics and Chief of the Division of Neonatology. He currently serves as Chairman of the Department of Pediatrics and Associate Dean for Managed Care, and continues to serve as Division Chief in Neonatology and Medical Director of the Neonatal Intensive Care Unit at Wolfson Children’s Hospital. Dr. Hudak is a versatile and productive academic researcher in clinical neonatology and community outreach and has publications in the New England Journal of Medicine, JAMA, Pediatrics, and other prestigious journals. He served as the Lead Investigator for the NIH National Children’s Study in Baker County, Florida from 2008-2013 and oversaw a project that exceeded its goals for recruitment, retention, and data quality. Dr. Hudak was a founding member of the FDA Pediatric Advisory Subcommittee and was appointed in 2013 to the FDA Pediatric Advisory Committee and the Neonatology Subcommittee. He was a member of the AAP Committee on Drugs for seven years and in 2014 was selected to chair the AAP Committee on Child Health Finance. He sits on the Florida Medicaid Pharmacy and Therapeutics Committee. He was chosen as the first Robert C. Nuss Scholar of the Year for the UF College of Medicine – Jacksonville in 2011. He remains an active clinical member of the team of highly trained, Board Certified Neonatologists that provides 24-hour care at Jacksonville’s two Level Ill Neonatal Intensive Care Units at UF Health Jacksonville and Wolfson Children’s Hospital, as well as other hospitals in Jacksonville and the surrounding region.

JanssonLLauren Jansson MD is an Associate Professor of Pediatrics at Johns Hopkins University School of Medicine in Baltimore, Maryland. She is a developmental pediatrician and the Director of Pediatrics at the Center for Addiction and Pregnancy, a multidisciplinary, comprehensive care treatment facility for pregnant and postpartum drug dependent women and their children. read more

She has provided pediatric care exclusively to drug-exposed infants and children. Her principal areas of research are methadone maintenance and lactation, fetal neurobehavioral development in drug dependent women, and neonatal abstinence syndrome resulting from in utero opiate exposure. Dr. Jansson has contributed to numerous publications on the subject of neonatal abstinence syndrome including the Academy of Breastfeeding Medicine Guidelines for Breastfeeding and the Drug-Dependent Woman. Breastfeeding Medicine 2009;4(4):225-228. Dr. Jansson is currently funded with an NIH and NIDA grant evaluating the fetal and infant effects of maternal buprenorphine treatment.

MarcellusL Lenora Marcellus RN, BSN, MN, PhD* is an Assistant Professor in the School of Nursing at the University of Victoria (UVIC). She began working as an RN in the NICU in 1986 and since then has served in multiple capacities, including clinical nurse specialist, administrator, and strategic planner, both in hospital, health authority and provincial government settings related to maternal-infant care. read more

Dr. Marcellus has a long-standing interest in the issue of perinatal substance use and neonatal withdrawal. She developed a specialized training program in 1997 for foster parents who care for infants with prenatal substance exposure in British Columbia (http://www.fpsss.com/safe_babies_program.html). This program is currently being adapted and implemented in Alberta, and was the recipient of the 2010 Sick Kids Rotman Innovation in Pediatric Home Care Award. Dr. Marcellus has also been involved with developing specialized programs for pregnant women with addictions and other complex social challenges. The HerWay Home program has been recently launched in Victoria with the support of the Children’s Health Foundation of Vancouver Island. She is a member of the Canada FASD Research Network team on the prevention of FASD. Additionally, Dr. Marcellus has also recently completed the Quality Academy through the British Columbia Patient Safety and Quality Council and is a representative for University of Victoria on the British Columbia Health Quality Network and the British Columbia Academic Health Council Working Group on Quality and Safety in Post-Secondary Health Professional Programs.

AbrahamsRRonald Abrahams MD is a family physician in Vancouver. He is a Clinical Professor in the Department of Family Practice at the University of British Columbia and Medical Director of Perinatal Addictions at British Columbia Women’s Hospital as well as consultant physician at the Sheway Program.Dr. Abrahams is the founding Medical Director of the FIR (Families In Recovery) Rooming in program at British Columbia Women’s Hospital-the first of its kind in North America. read more

Since its inception 10 years ago, over 1200 women, infants, and families have benefited from this program. The unit has been named a “leading practice” by the Canadian Council of Health Accreditation, cited in the 2007 Kroeger Award for improving outcomes. During the last 27 years Dr. Abrahams has been recognized as an invited speaker nationally and internationally to present evidenced-based harm reduction guidelines and protocols for women with problematic substance use in pregnancy. He is an Associate of the School of Population and Public Health at the University of British Columbia and a clinical investigator with the Women’s Health Research Institute and a consultant to the Austria-American Institute and the Open Society Institute. Dr. Abrahams received the 2008 Kaiser Foundation National Award for Excellence in Leadership for Harm Reduction Programs.

DeppenK Krisanna Deppen MD is board certified in Family Medicine and Addiction Medicine. After graduating from Northeastern Ohio Universities College of Medicine, she completed her family medicine residency at Grant Medical Center in Columbus, Ohio. She completed an Addiction Medicine Fellowship at Swedish Medical Center in Seattle Washington where her passion for caring for pregnant women with substance abuse disorder began. read more

She currently works at OhioHealth-Grant Medical Center working with the family medicine residency and the inpatient pain management team. Her clinical practice focuses on the care of pregnant women with opioid dependence and their newborns.

DiGiuseppeRRobert DiGiuseppe MD graduated medical school from the Medical University of South Carolina (MUSC). He next completed a pediatric residency at Greenville Hospital System in Greenville, SC. After residency he relocated to Indianapolis, Indiana to complete a fellowship in neonatal-perinatal medicine at Indiana University. He moved to Wilmington, NC in 2011 to join Coastal Carolina Neonatology (CCNEO) and is currently the Medical Director of the NICU Follow Up Clinic at New Hanover Regional Medical Center. He also serves on the Board for the March of Dimes and the Interdisciplinary Neonatal Follow-Up and Treatment Services (INFANTS).

FranckL Linda Franck RN, PhD, FRCPCH, FAAN Professor & Chair, Department of Family Health Care Nursing at the University of California. Dr. Franck’s program of research focuses on health care for acutely and chronically ill infants and children, in primary, secondary and tertiary care settings, with a particular emphasis on pain assessment and management. read more

This includes research on the assessment and management of side effects of analgesia and sedation, as well as investigation of the long term consequences of pain and pain treatments on the developing child and family. Her most recent research highlights the information needs of parents and suggests innovative strategies for enhancing the partnership between parents and professionals to ensure children receive optimal health care before, during and after a child’s hospitalization.

JacksonJJodi Jackson MD is an Associate Professor of Pediatrics in the Division of Neonatology, Children’s Mercy Hospital. Originally from Chicago, she graduated from The University of Illinois School of Medicine and completed her pediatric residency at the Mayo Clinic, Rochester, MN. She then went on to complete her Neonatal Fellowship at Children’s Mercy Hospital in 2002. read more

Through the clinic partnership between Children’s Mercy Hospital and Shawnee Mission Medical Center (SMMC), she now serves as Medical Director of the NICU at SMMC, as well as its medical director of quality improvement. She was recently nominated for a Physician of Excellence in Teamwork award at SMMC. Dr. Jackson’s non-clinical activities and many of her publications and presentations have been centered on patient safety, quality improvement and evidence-based practice. Through her initial involvement with Vermont Oxford Network 1999 – 2007, and later involvement with IHI and local hospital committees, she has worked with multidisciplinary teams to improve adherence to accepted guidelines and standardized practice in an effort to assure the delivery of safe, effective and efficient patient centered care.

KaltenbachK Karol Kaltenbach PhD* is a Professor of Pediatrics and Professor of Psychiatry and Human Behavior and the Director of Maternal Addiction Treatment, Education and Research (MATER), a division of the Department of Pediatrics, Jefferson Medical College. MATER includes “Family Center”, a comprehensive intensive outpatient treatment program for pregnant and parenting opioid dependent women; “My Sister’s Place”, a long-term residential treatment program for women and children; and a research component. read more

 Family Center has provided the prototype both nationally and internationally for the management of opioid dependency during pregnancy and the treatment of neonatal abstinence. She is a member of the College on Problems of Drug Dependence and has been the principle investigator of grants from the National Institute on Drug Abuse (NIDA) and the Center for Substance Abuse Treatment. She was the principal investigator at the Jefferson site for the NIDA MOTHER clinical trial comparing the use of buprenorphine and methadone in the treatment of opioid dependence during pregnancy. Dr. Kaltenbach is the lead principal investigator of the MOTHER developmental follow-up study, and is a co-investigator of a NIDA funded clinical trial investigating the use of buprenorphine in the treatment of neonatal abstinence syndrome (NAS). Dr. Kaltenbach is an internationally recognized expert in the field of maternal addiction and has published extensively on the management of opioid dependence during pregnancy and NAS. She co-authored the 1992 publication of the Neonatal Abstinence Score with Loretta Finnegan and in addition to the NEJM publication of the MOTHER primary results, she has published secondary analyses of MOTHER data examining predictors of treatment for NAS and differences in the profile of NAS signs as a function of prenatal methadone or buprenorphine exposure. She has participated in the development of national guidelines for the management of opioid dependent pregnant women and their neonates in Australia and Norway.

KeelsEErin Keels RN, MS, NNP-BC has been a neonatal nurse for 26 years and a Neonatal Nurse Practitioner for 20 years at Nationwide Children’s Hospital (NCH) in Columbus, Ohio. As the NCH NAS Taskforce Chairperson, she has led a multidisciplinary team of maternal and neonatal providers and staff in the continuous improvement of services for patients and families with NAS. She has lectured nationally on the topic of NAS and has served as expert faculty at the state and national levels for NAS quality and educational initiatives.

KnappenBBetsy Knappen BSN, APRN is a Neonatal Nurse Practitioner at Children’s Mercy Hospital and services Shawnee Mission Medical Center as well as Truman Medical Center. She has been an NNP for 23 years. Betsy serviced as the Clinical Nurse Specialist for three years at Shawnee Mission during the building of their new Birthing Center and NICU. read more

She has been involved in many quality improvement projects and key initiatives for Shawnee Mission. Betsy was also involved with the initial development projects for Children’s Mercy’s Fetal Health Center. Prior to working at Children’s Mercy Hospital, Betsy worked for Research Medical Center as an NNP. She coordinated the NICU education, was involved in a drug comparison study and sat on the NNP management committee.
KraftW Walter K. Kraft MS, MD* is Associate Professor, Department of Pharmacology and Experimental Therapeutics, Director, Clinical Research Unit, Faculty, College of Graduate Studies, and Vice Chair, Institutional Review Board Committee at Jefferson Medical College. Dr. Kraft has expertise in the clinical, regulatory, and managerial aspects of Phase 1 drug development. His research interests include: phase one clinical trials, clinical pharmacology and treatment of neonatal abstinence syndrome.

WhalenBBonny Whalen MD is an Assistant Professor of Pediatrics at the Geisel School of Medicine at Dartmouth. Dr. Whalen received her MD degree from the University of Vermont College of Medicine and completed her Pediatrics Residency at the Massachusetts General Hospital in Boston, MA. She then spent six years as a general pediatrician and newborn hospitalist at the University of Wisconsin in Madison, WI before moving back to New England in 2005. read more

She has spent the last 8+ years as a general pediatrician specializing in newborn care, working as a newborn / pediatric hospitalist and Newborn Nursery Medical Director at the Children’s Hospital at Dartmouth / Dartmouth-Hitchcock Medical Center. Dr. Whalen is co-leading quality improvement efforts in her hospital and region to improve care for newborns at risk for and/or with Neonatal Abstinence Syndrome. Her work focuses on increasing staff consistency in NAS scoring, improving family involvement in care of their newborns, empowering families to best care for their newborns through prenatal education and in-hospital support, and increasing breastfeeding rates in this vulnerable population through encouraging abstinence prenatally and communicating with a mother’s outpatient treatment provider and the baby’s medical home to ensure safe breastfeeding after discharge. Dr. Whalen is currently co-leading a qualitative study on the hospital experience of families as it relates to a mother’s opiate exposure in pregnancy and care of her newborn postnatally. Dr. Whalen has also performed extensive outreach education in her region on care of the opiate-exposed newborn and evidence-based perinatal breastfeeding support.

Buus-FrankM Madge Buus-Frank DNP, APRN-BC, FAAN** serves as Director of Quality Improvement and Education at the Vermont Oxford Network and has been actively engaged in neonatal care for over three decades. Madge is an honors graduate from Boston College and the University of Connecticut, where she recently earned her Doctorate in nursing. read more

Her doctoral dissertation focused on evaluating the effectiveness and stability of Helping Babies Breathe in Zambia. Madge is an internationally recognized educator and consultant. Prior to her role at VON, she collaborated on the design, development, and execution of innovative educational and clinical solutions for newborn intensive care units and health systems nationally and internationally. Madge was the founding Editor-in-Chief for Advances in Neonatal Care: The Official Journal of the National Association of Neonatal Nursing, a peer-reviewed publication dedicated to advancing the art and science of neonatal care, serving for five years in this capacity. Madge was recently inducted as a Fellow of the American Academy of Nursing (FAAN) for her pioneering work in the field of neonatal care.

HorbarJJeffrey D. Horbar MD* is a board-certified neonatologist and clinical scientist with extensive experience in clinical research and its application to the improvement of neonatal care. He is currently a Professor of Pediatrics at the University of Vermont College of Medicine, Chief Executive and Scientific Officer of the Vermont Oxford Network, Associate Editor of Pediatrics, and Co-Editor of the Neonatal Review Group of the Cochrane Collaboration.read more

Dr. Horbar has been responsible for the development of the Vermont Oxford Network Database which is used by over 900 NICUs around the world to monitor and improve outcomes for very low birth weight infants. He is the leader of the quality improvement initiatives of the Vermont Oxford Network including the National Evidence-Based Quality Improvement Collaborative for Neonatology, and the iNICQ Internet Improvement Collaboratives.

SollRRoger Soll MD*is the H. Wallace Professor of Neonatology at the University of Vermont College of Medicine, the President of the Vermont Oxford Network, and Director of Network Clinical Trials and Follow-up. Dr. Soll is an authority in evidence-based medicine and randomized clinical trials. He is the Coordinating Editor of the Cochrane Neonatal Review Group of the Cochrane Collaboration and author-or co-author of the Cochrane Reviews of surfactant therapy. read more

He is the author of numerous peer reviewed articles and book chapters on the subject of surfactant replacement therapy and evidence-based medicine. A native of New York City, Dr. Soll graduated from Cornell University with a degree in Genetics and History of Science in 1975. He received his M.D. degree from the University of Health Sciences/Chicago Medical School in 1978. He returned to New York City to complete his residency training in Pediatrics at Bellevue Hospital/New York University Medical Center in 1981. After 2 years with the Public Health Service, Dr. Soll returned to academic training. He completed the post graduate fellowship in Neonatal Perinatal Medicine at the University of Vermont in 1983 and has remained in Vermont ever since. When otherwise unoccupied, he resides in Hinesburg, Vermont with his wife, two sons, and a large golden retriever.

**Faculty and Steering Committee Lead

*Steering Committee Member

Return to top